Divi's Laboratories is currently trading at Rs. 3988.50, up by 147.75 points or 3.85% from it...
Divi’s Laboratories’ (DIVI IN) Q3FY24 revenue and EBITDA missed our es...
Divi's Laboratories' quarterly earnings fell below our projections across all metrics. Th...
We reduce our FY25E/FY26E EPS estimates by ~10%. Divi’s Laboratories (DIVI) Q3FY24 EBITDA w...
Divi's Laboratories is currently trading at Rs. 3751.95, up by 100.95 points or 2.76% from it...
Custom synthesis drives earnings Work in progress to enhance peptide opportunity * Divi&rsq...
Pharma major Divi's Laboratories on Saturday reported a 17 per cent increase in its consolida...
Pricing pressure in API segment hurts profitability CS segment sales to pick up pace in the co...
Divi's Laboratories is currently trading at Rs. 3514.80, up by 164.90 points or 4.92% from it...